✦ LIBER ✦

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma

✍ Scribed by Sally A. Hunsucker; Valeria Magarotto; Deborah J. Kuhn; Steven M. Kornblau; Michael Wang; Donna M. Weber; Sheeba K. Thomas; Jatin J. Shah; Peter M. Voorhees; Hong Xie; Mark Cornfeld; Jeffrey A. Nemeth; Robert Z. Orlowski

Book ID: 108677115
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 584 KB
Volume: 152
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08533.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Colony stimulating activity in the serum

Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma

✍ B. C. Millar; J. B. G. Bell; A. Montes; J. L. Millar; J. A. Maitland; J. Treleav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Optimizing the use of anti-interleukin-6

Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects

✍ Rossi, J-F; Fegueux, N; Lu, Z Y; Legouffe, E; Exbrayat, C; Bozonnat, M-C; Navarr 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB